Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Adrenoleukodystrophy (cALD)”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Large-scale testing (Phase 3)Study completedNCT01896102
What this trial is testing

The Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Who this might be right for
Cerebral Adrenoleukodystrophy (CALD)
Genetix Biotherapeutics Inc. 32
Not applicableNot Yet RecruitingNCT05911919
What this trial is testing

Validation of a Prognostic Biomarker Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy

Who this might be right for
X-linked Adrenoleukodystrophy
Assistance Publique - Hôpitaux de Paris 200
Not applicableEnded earlyNCT02204904
What this trial is testing

Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)

Who this might be right for
X-Linked Adrenoleukodystrophy (X-ALD)Cerebral Adrenoleukodystrophy (CALD)Adrenoleukodystrophy (ALD)
Genetix Biotherapeutics Inc. 59
Large-scale testing (Phase 3)Study completedNCT03852498
What this trial is testing

A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Who this might be right for
Cerebral Adrenoleukodystrophy (CALD)
Genetix Biotherapeutics Inc. 35
Large-scale testing (Phase 3)Looking for participantsNCT05819866
What this trial is testing

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

Who this might be right for
Cerebral Adrenoleukodystrophy (cALD)
Minoryx Therapeutics, S.L. 40
Testing effectiveness (Phase 2)Ended earlyNCT03367546
What this trial is testing

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases

Who this might be right for
Sickle Cell DiseaseThalassemiaHigh Risk Hematologic Disorders+2 more
Masonic Cancer Center, University of Minnesota 5
Testing effectiveness (Phase 2)Ended earlyNCT05394064
What this trial is testing

Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)

Who this might be right for
AMNAMN Gene MutationX-ALD
SwanBio Therapeutics, Inc. 8
Not applicableLooking for participantsNCT06224413
What this trial is testing

Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

Who this might be right for
Cerebral Adrenoleukodystrophy (CALD)
Genetix Biotherapeutics Inc. 120
Not applicableEnded earlyNCT05008874
What this trial is testing

Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia

Who this might be right for
AMNAMN Gene MutationX-ALD
SwanBio Therapeutics, Inc. 65
Early research (Phase 1)Temporarily pausedNCT06030648
What this trial is testing

MT2022-01: MSCs for ALD

Who this might be right for
Cerebral Adrenoleukodystrophy
Masonic Cancer Center, University of Minnesota 10
Early research (Phase 1)WithdrawnNCT02410239
What this trial is testing

MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)

Who this might be right for
Cerebral Adrenoleukodystrophy
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)UnknownNCT04528706
What this trial is testing

A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)

Who this might be right for
Cerebral Adrenoleukodystrophy
Minoryx Therapeutics, S.L. 13
Not applicableActive Not RecruitingNCT02698579
What this trial is testing

Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

Who this might be right for
Cerebral Adrenoleukodystrophy (CALD)Adrenoleukodystrophy (ALD)X-Linked Adrenoleukodystrophy (X-ALD)
Genetix Biotherapeutics Inc. 64